Loading…

Sepratec, a subsidiary of Enbionia, signed a contract on November 3, 2022 with a Chinese medical company to supply equipment for manufacturing artificial lung membranes, valued at approximately KRW 2.1 billion.
“이번 계약은 당사가 보유한 기술을 필요로 하는 산업분야가 점차 확대되고 있다는 반증”venturesquare.net
Summarized from public sources; check the original articles before acting on it.